The Biden-Harris administration yesterday sent Congress its first-year drug policy priorities, as required by each new administration. 

They call for expanding access to evidence-based treatment; advancing racial equity in drug policy; enhancing evidence-based efforts to reduce harm; supporting evidence-based efforts to prevent youth substance use; reducing the supply of illicit substances; removing barriers to employment for people in recovery and expanding the addiction workforce; and expanding access to recovery support services.
 

Related News Articles

Headline
Data from the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill shows that health care cuts under…
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…
Headline
Sens. Chuck Schumer, D-N.Y., Susan Collins, R-Maine, and Andy Kim, D-N.J., June 5 reintroduced the SEPSIS Act, legislation which would task the Centers for…
Perspective
Public
After approval in the House last week by a one vote margin, the One Big Beautiful Bill Act — a sweeping package that would enact many of President Trump’s…
Headline
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on…
Headline
The House Budget Committee May 18 advanced the fiscal year 2025 budget reconciliation bill by a 17-16 vote along party lines, as four Republicans who…